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Hyperglycemia induced reactive oxygen species (ROS) generation is believed as major factors leading to diabetic nephropathy
(DN). DangGui (Angelica sinensis)i sm e n t i o n e dt os h o wr e n a lp r o t e c t i v ee ﬀect in combination with other herbs. Bone
morphogenetic proteins-7 (BMP-7) is produced merit in protection of DN. The role of BMP-7 in DangGui-induced renal
improvement is not clear. The present study investigated the eﬀects of DangGui on renal functions, BMP-7 expression and the
levels of ROS in streptozotocin (STZ)-induced diabetic rats and high glucose-exposed rat mesangial cells (RMCs). After 1- or 4-
week treatment, DangGui improved renal functions and increased renal BMP-7 expression in diabetic rats. The BMP-7 expression
in RMCs was reduced by high glucose treatment and this could be reversed by DangGui. Moreover, RMCs exposed to high glucose
were expired by BMP-7 RNAi transfection but those cells remained alive by scramble transfection. Thus, we employed regular
RMCstoknockdownBMP-7withRNAiandwefoundthatDangGuiincreasedBMP-7expressionintheseRMCs.Directactivation
of BMP-7 expression by DangGui could be considered. The results of DPPH assay, DHE stain and lucigenin assay indicated that
DangGui could inhibit high glucose-induced ROS in RMCs. These results suggest that DangGui has an ability to improve renal
functions in STZ-diabetic rats through increasing endogenous BMP-7 expression and decreasing oxidative stress in kidney. The
present study suggest that DangGui could be applied to improve renal functions in diabetic disorders.
1.Introduction
Many diabetic patients developed nephropathy and/or end-
stage renal disease (ESRD) and the prevalence has progres-
sively increased in recent [1]. Hyperglycemia is introduced
as the main factor to induce diabetic nephropathy (DN).
ClinicalstrategiesforDNincludeglycemiccontrolandblood
pressure regulation [2, 3] while the therapeutic eﬀect is not
satisﬁed.
DangGui is the mandarin of dried root of Angelica sinen-
sis. It is widely used in traditional Chinese medicine (TCM)
to promote blood circulation and enrich blood, which
usually means to increase the number of blood cells with
improving their function. DangGui increases the secretion
of many hematopoietic factors, such as interleukins, EPO,
TPO, GM-CSF, TNF-α and IFN-γ from cells [4, 5]. DangGui
could induce the proliferation of murine bone marrow
mononuclear cells by activating ERK1/2 and P38 MAPK2 Evidence-Based Complementary and Alternative Medicine
pathway[6]. DangGui also showed antiproliferative and pro-
apoptotic activities in hepatic stellate cells (HSC-T6) [7]. In
TCM, DangGui (Angelica sinensis)a n dH u a n gQ i( Astragalus
membranaceus) are traditionally used along with each other
[8]. The mixture of DangGui and Huang Qi is named
as DangGui-Bu-Xue-Tang (GQM) that could alleviate the
progression of DN in streptozotocin (STZ)-induced diabetic
rats probably due to the lowering of angiotesin II and TGF-
β mRNA [9, 10]. The antiﬁbrotic action of GQM has been
compared with an ACE inhibitor, enalapril, in puromycin-
induced acute nephrosis animal model. The results showed
that GQM could decrease proteinuria and BUN in addition
to the lower expressions of TGF-β, collagen types III and
IV, laminin and ﬁbronectin [11]. In this study, we examined
whether DangGui could show the renal protective eﬀect.
Bone morphogenetic protein-7 (BMP-7) could reduce
glomerular and tubulointerstitial ﬁbrosis and prevent the
pathogenesis in diabetic nephropathy [12–16]. BMP-7 im-
proves renal damage from hyperglycemia-induced oxidative
stress in the kidney of diabetics [13, 14]. We also observed
that control of hyperglycemia may improve renal function
and reverse renal BMP-7 expressions at the initial stage of
DN but not at the late stage of DN in type-1-like diabetic rats
[12]. Hyperglycemia causes oxidative stress in renal cell that
is implicated in the development of DN [17]. Endogenous
BMP-7 could be raised by an anti-oxidant to activate the
receptors for renal protection against the damage from high
glucose (HG) [14]. The role of endogenous BMP-7 in the
protection of DN seems important. However, the role of
BMP-7 in the renal improvement eﬀect of DangGui remains
obscure. The present study is designed to investigate the
eﬀect of DangGui on renal functions and BMP-7 expression
in STZ-diabetic rats. We also determined the eﬀect of Dang-
Gui on reactive oxygen species (ROS) generated from hyper-
glycemia.
2. Methods
2.1. DangGui Preparation. The concentrated granules of
DangGui, made of 98% pure authentic Chinese herbs of
highest qualities, are produced by Han-Sheng Pharmtech,
Inc. (Ping-Tong City, Taiwan) under internationally certiﬁed
Good Manufacturing Practices guidelines. The macroscopic
and microscopic examinations as well as thin-layer chro-
matography and high-performance liquid chromatography
were used to identify the plants. The reference specimens
were deposited at the herbarium of the supplier.
2.2. Animal Model for Diabetic Nephropathy. Six-week-old
male Wistar rats, 180–200g in weight, were obtained from
the Animal Center of National Cheng Kung University Med-
icalCollege.STZ-diabeticratswereinducedbyintravenously
(i.v.) injecting STZ (65mg/kg) (Sigma-Aldrich Inc., St Louis,
MO, USA) into fasting rats as described previously [18].
Animals were considered to be diabetic if they had elevated
plasma glucose concentrations of 350mg/dL. All experi-
ments were carried out at 9 weeks after the STZ-DN in-
duction. STZ-diabetic rats were considered to have diabetic
nephropathy(DN)whentheyhadelevatedlevelsofBUNand
creatinine. All animal procedures were performed according
to the guide for the care and use of laboratory animals of the
National Institutes of Health. STZ-diabetic rats were treated
with 5mg/kg of DangGui or 1mg/kg of ramipril twice a day
for 1 or 4 weeks. The STZ-diabetic rats were divided into
four groups (n = 6), respectively: vehicle-treated normal
rats; vehicle-treated STZ-diabetic rats; DangGui-treated STZ
diabetic rats; ramipril-treated STZ-diabetic rats.
2.3.BloodGlucoseandRenalFunctionsDetermination. Blood
samples were collected from the rat femoral vein before the
treatment and 1h after the last treatment for estimating the
levelsofplasmaglucose,ureanitrogen(BUN)andcreatinine.
The body weights were monitored during the experiment. At
the end of the treatment, animals were killed and the kidneys
were dissected, washed with saline, weighted for analysis
and frozen in liquid nitrogen and then stored at −80◦Cf o r
further analysis. Blood samples from rats were centrifuged at
12000g for 3min. We incubated samples with glucose, BUN
or creatinine kit reagents (AppliedBio assay kits; Hercules,
CA, USA). The levels of blood glucose, BUN and serum cre-
atinine were then estimated by the auto-analyzer (Quik-Lab,
Ames, Miles Inc., Elkhart, Indiana, USA) run in duplicate.
2.4. DPPH Radical Scavenging Assay. The antioxidant activ-
ity of DangGui and ascorbic acid (vitamin C) was measured
in terms of 1,1-diphenyl-2-picrylhydrazyl (DPPH) (Sigma-
Aldrich Inc., St Louis, MO, USA) free radical scavenging
ability, with slight modiﬁcation. Vitamin C was used as a ref-
erence compound. The highest tested concentration of Vita-
min C was considered as 100% of scavenging activity. A
solution of DangGui at diﬀerent concentrations was placed
in a cuvette and 1mL of 23.7μg/mL methanol solution of
DPPH radical was added followed by incubation for 30min.
The decrease in absorbance at 517nm was determined with
a spectrophotometer. All determinations were performed in
three replicates. The percentage inhibition of DPPH radical
by the samples was calculated according to the following
formula:
Percentage of scavenging of DPPH =

1 −
A(s)
A(c)

× 100,
(1)
where A(c) is the absorbance of the control (without sample)
and A(s) is the absorbance of the sample at t = 30min.
2.5. RMCs Cultures. The cell line, rat mesangial cells
(RMCs), was purchased from the American Type Culture
Collection (Manassas, VA, USA). RMCs were cultured in
Dulbecco’s modiﬁed Eagle’s medium (DMEM; Gibco-BRL,
Gaithersburg, MD, USA) containing 5mmol/L glucose sup-
plemented with 15% FBS and antibiotics at 37◦C in 95% air,
5% CO2. We added 25mmol/L glucose (ﬁnal concentration
30mmol/L) into serum-free DMEM for a HG medium. We
use DMEM without FBS and additional glucose as a control
medium. After ∼60% conﬂuent monolayer, the culture me-
dium was displaced by control or HG medium with diﬀerentEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Eﬀects of DangGui on the levels of blood glucose (a), BUN (b), creatinine (c) and kidney/body weight ratio (d) in STZ-diabetic
rat after 1-week DangGui (5mg/kg) or ramipril (1mg/kg) treatment. ∗P < 0.05 values of STZ-diabetic rats compared to the value of vehicle-
treated normal rats. #P < 0.05 the signiﬁcance for values of after treatment compared to treatment before.
treatments and then cultured for 24h. DangGui (200μg/mL)
and tiron (10mmol/L; 4,5-dihydroxyl-1,3-benzene disul-
fonic acid; Sigma-Aldrich Inc., St Louis, MO, USA) were
used.
2.6. Small Interfering RNA of BMP-7 Transfection. Duplexed
RNA oligonucleotides for rat BMP-7 (Stealth RNAi TM)
were synthesized by Invitrogen (Carlsbad, CA, USA). RMCs
were transfected in combination with 40pmol/L of BMP-7-
speciﬁc small interfering RNA (siRNA) or scramble siRNA
using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s protocols. The sequences of the BMP-7
Stealth RNAi (Bmp7-RSS340413) are (sense strands, 5 –3 )
UGA UGUCAAAUACCAACCAGCCCU C and (antisense
strands, 5 –3 ) GAGGGCUGGUUGGUAUUUGACAUCA.
After 12-h incubation in the transfection conditional me-
dium for maximum target gene inhibition, it was changed
to the regular culture medium with DangGui (200mg/mL)
for 24 h and analyzed.
2.7. Intracellular ROS Detection. The 10000 of RMCs were
seeded on 12-well cell culture plates. After 24h growth,
RMCs were placed in control or HG medium and treated
with tiron (10μmol/L) or DangGui (200μg) for further 24-h
incubation and then harvested. The RMCs were ﬁxed with
3.7% paraformaldehyde. Thirty minutes after cell ﬁxation
andthreetimeswashwithPBS,5μmol/Lofdihydroethidium
(DHE; Invitrogen) was added as a ﬂuorescent indicator
of ROS generated in response to the described treatment.
Images were collected with an Olympus IX70 ﬂuorescence
microscope ﬁtted with an Olympus America camera and
MagnaFire 2.1 software.
2.8. Measurement of Superoxide Generation. Superoxide pro-
duction was determined by the lucigenin method. RMCs
were incubated in the NG (control) or HG medium for 24h
in the absence or presence of various treatments described
above. Then, RMCs were trypsinized and collected by
centrifugation, and the pellet was washed in the modiﬁed4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀects of DangGui on the levels of blood glucose (a), BUN (b), creatinine (c) and kidney/body weight ratio (d) in STZ-diabetic
rat after 4-week DangGui (5mg/kg) or ramipril (1mg/kg) treatment. The diﬀerent treatments on rats are described in the Materials section.
∗P < 0.05 values of STZ-diabetic rats compared to the value of vehicle-treated normal rats. #P < 0.05 is the signiﬁcance for values after
treatment compared to treatment before.
Krebs buﬀer containing NaCl (130mmol), KCl (5mmol),
MgCl2 (1mmol), CaCl2 (1.5mmol), K2HPO4 (1mmol) and
HEPES (20mmol), pH 7.4. After washing, the RMCSs were
resuspended in the Krebs buﬀer with 1mg/mL BSA, and
the cell concentration was adjusted to 1 × 107 in 900μL
buﬀer. To measure ROS production, the cell suspension was
transferred into the measuring chamber and assessed in a
Chemiluminescence Analyzer (Tohoku Electronic Industrial
Co., Ltd, Japan). Measurement was started by an injection
of 100μl lucigenin (ﬁnal concentration, 4 × 10
−4 mmol/L).
Photon emission was counted every 10s for up to 10min.
2.9. Western Blot Analysis for Kidney and RMCs. BMP-7 ex-
pressions in rat kidney or RMCs were determined by western
blotting analysis. We use the RIPA buﬀer to extract total
protein. For western analysis, proteins were separated by
SDS-PAGE, transferred and immobilized on a nitrocellulose
membrane.Themembranewasblockedwith5%non-fatdry
milk in phosphate buﬀered saline containing 0.1% Tween
20 (PBS-T) for 2-h incubation at room temperature. The
membrane was then washed in PBS-T and hybridized with
primaryantibodiesdilutedtoaproperconcentrationinPBS-
T for 16h. Speciﬁc antibodies (Santa Cruz Biotechnology
Inc., Santa Cruz, CA, USA) for BMP-7 (diluted in 1:200)
and β-actin (diluted in 1:1000) were used. Incubation with
secondary antibodies and detection of the antigen-antibody
complex were performed using the ECL kit (Amersham
Biosciences, UK). Densities of the obtained immunoblots
were quantiﬁed using a laser densitometer.
2.10. Statistical Analysis. Results were expressed as mean ±
SE. Statistical analysis was carried out by using ANOVA
analysis and Newman-Keuls post hoc analysis. Statistical sig-
niﬁcance was achieved if P < 0.05 or P < 0.001.Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Change of the BMP-7 level in the kidney of STZ-diabetic rat after 1-week (a) or 4-week (b) treatment of DangGui (5mg/kg) or
ramipril (1mg/kg). Western blotting analysis of BMP-7 expression was carried out in the kidney of 9-week STZ-diabetic rat. Upper picture
shows the protein level of BMP-7 or β-actin in kidney isolated from STZ-diabetic rat. The diﬀerent treatments on rats are described in the
Materials section. Quantiﬁcation of protein level using BMP-7/β-actin expressed as mean ± SE (n = 4 per group) in each column is indicated
in the lower panel. ∗P < 0.05 compared to the value of vehicle-treated normal rats.
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Figure 4: Eﬀect of DangGui on the BMP-7 level in high-glucose-
treated RMCs. RMCs were cultured in normal glucose (5mmol/L;
Con) or high-glucose (30mmol/L; HG) medium in the presence
of 200μg/mL DangGui (DG) for 24h incubation. Western blot
analysis of BMP-7 expression in RMCs. Upper picture shows the
protein level of BMP-7 or β-actin in RMCs. The conditional
treatments on RMCs are described in the Materials and meth-
ods section. Quantiﬁcation of protein level using BMP-7/β-actin
expressed as mean ± SE (n = 4 per group) in each column is
indicated in the lower panel. ∗P < 0.05 compared to the value of
control medium.
3. Results
3.1. Eﬀect of DangGui on Renal Functions in STZ-Diabetic
Rats. Wistar rats were injected with STZ to induce type-
1 like diabetic animal. After 9 weeks, the serum levels of
glucose, BUN, creatinine and kidney weight in STZ-diabetic
rats were signiﬁcantly higher than normal rats (P < 0.05)
(Figure 1). We treated angiotensin-converting enzyme in-
hibitor, ramipril [19], to STZ-diabetic rats as positive con-
trol. After treatment with DangGui or ramipril for 7 days,
the serum levels of BUN and creatinine and kidney weight in
STZ-diabetic rats were eﬀectively reversed but these eﬀects
were not shown on glucose (Figures 1(a)–1(d)). The serum
levels of BUN and creatinine in 4-week vehicle-treated STZ-
diabetic rats (Figures 2(b) and 2(c)) were higher than those
in1-weekvehicle-treatedSTZ-diabeticrats(Figures1(b)and
1(c)). Four-week treatment of DangGui or ramipril could
improve the renal functions and decrease kidney weight of
STZ-diabetic rats (Figures 2(a)–2(d)).
3.2. Recovery of BMP-7 in Kidney and RMCs by DangGui.
ChangesofrenalBMP-7expressionofSTZ-diabeticratswere
analyzed using western blot. BMP-7 expression in the kidney
of STZ-diabetic rats was reduced in a way related to diabetic
induction (35% decreased in 9-week STZ-diabetic rats and
50% decreased in 13-week STZ-diabetic rats as compared
to normal rats) (Figures 3(a) and 3(b)). After DangGui or
ramipril administration, BMP-7 expressions in the kidney
were increased in both 1- and 4-week-treated STZ-diabetic
rat (Figures 3(a) and 3(b)).6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Eﬀect of DangGui on BMP-7 protein in RMCs-treated
BMP-7 siRNA. RMCs were cultured in scramble siRNA (Con) or
BMP-7siRNA(siBMP-7)transfectionconditionalmediumfor12h.
RMCs were cultured in normal glucose (5mmol/L) medium in the
presence of 200μg/mL DangGui (DG) after being transfected with
scramble siRNA (Con+DG) or BMP-7 siRNA (siBMP-7+DG) for
further 24h incubation. Western blot analysis of BMP-7 expression
inRMCs.UpperpictureshowstheproteinlevelofBMP-7orβ-actin
in RMCs. The conditional treatments on RMCs are described in the
Materials section. Quantiﬁcation of protein level using BMP-7/β-
actin expressed as mean ± SE (n = 4 per group) in each column is
indicated in the lower panel. ∗P < 0.05 compared to the value after
DangGui treatment.
Then, we conﬁrmed the direct eﬀect of DangGui on
BMP-7 expression in vitro. In the preliminary tests (data
not shown), we found that BMP-7 expression in RMCs was
reduced markedly by high glucose incubation after 24h but
it could not be increased by DangGui within 12h. Thus, we
investigated the eﬀect of DangGui on BMP-7 expression in
RMCs after the 24-h incubation. The BMP-7 expression in
high glucose-treated RMCs was markedly decreased and it
can be reversed by DangGui treatment for 24h (Figure 4).
The small interference RNA of BMP-7 (siBMP-7) and
scramble RNAi were then employed to identify the role of
BMP-7inthisactionofDangGui.ThelevelofBMP-7protein
expression was markedly reduced after siBMP-7 transfection
in RMCs cultured in the normal medium. But the same
siBMP-7 transfection led to cell death in RMCs incubated
with the high glucose medium. Thus, we have to give up the
study in the high glucose medium. The BMP-7 expression
of RMCs was inhibited by over 75% after 12-h siBMP-
7 transfection comparing to scramble RNAi transfection
(Figure 5, lanes 1 and 2). After 12-h transfection, we treated
DangGui to those RMCs and incubated for further 24h.
The results showed that DangGui could increase the BMP-
7 expression in scramble RNAi-transfected RMCs (Figure 5
and lane 3). The decreased BMP-7 protein by siBMP-7
transfectioncouldbereversedbyDangGuitreatmentfor24h
(Figure 5 and lane 4).
3.3. DangGui Decreased Reactive Oxygen Species (ROS). The
direct ROS scavenging eﬀect of DangGui was evaluated
using theDPPHradicalscavenging assay. Figure 6(a)showed
that DangGui could scavenge the free radicals directly in a
concentration-dependent manner similar to vitamin C.
3.4. DangGui Decreases High-Glucose-Induced ROS in RMCs.
In the previous study [14], ROS was characterized to be
raised in RMCs incubating with a HG medium and this
can be reduced by rhBMP-7. The antioxidative ability of
DangGui was visualized by DHE stain (Figure 6(b))a n d
measured by the lucigenin assay (Figure 6(c)). We observed
that ROS increased in RMCs by HG was markedly inhibited
by DangGui in a way similar to tiron. The lucigenin assay
revealed that BMP-7 could lower the high glucose-induced
superoxide generation in RMCs.
4. Discussion
In present study, we found that DangGui improved the renal
functions and increased BMP-7 expression in the kidney of
STZ-diabetic rat. DangGui could directly increase endoge-
nous BMP-7 and decrease ROS induced by HG in RMCs.
We used STZ to induce type-1 like diabetic rats as described
previously [18]. Development of DN is widely characterized
usingthehigherplasmalevelsofcreatinineandBUNinSTZ-
induced diabetic rats. In our study, the renal functions of the
STZ-induced diabetic rats showed typical features of DN as
described previously [20, 21]. Following the previous reports
[22], 1-week-treated STZ-induced diabetic rats belong to
the initial stage of DN and 4-week-treated STZ-induced
diabetic rat are deﬁned as the established stage and/or late
phase of DN. Both stages of DN were improved by DangGui
treatment in the present study.
BMP-7isobservedtoexpressmostlyinadultmammalian
kidney to help maintain renal structure and physiological
function while BMP-7 expression decreased in damaged kid-
ney [22]. Exogenous BMP-7 is mentioned to improve renal
function and prevent glomerular sclerosis in diabetic rats
[23, 24]. However, BMP-7 fails to attenuate the protein over-
load-induced renal interstitial ﬁbrosis [24]. Thus, the reserve
ofendogenousBMP-7inthekidneytopreventinjuriesseems
to be pivotal. We found that renal BMP-7 expression was
lowered in both 1- or 4-week vehicle-treated STZ-diabetic
rats. After 1-week treatment, DangGui improved renal func-
tions and increased BMP-7 expression in type-1 like diabetic
rats. These actions of DangGui were more eﬀective in 4-
week-treated diabetic rats than in 1-week-treated diabetic
rats. To understand the changes of BMP-7 in the kidney
of rats with DN, we employed the cultured mesangial cells
(RMCs) to mimic the in vivo changes. Hyperglycemia causes
oxidative stress and leads to increased levels of transforming
growth factor-β (TGF-β) and increased production of extra-
cellular matrix (ECM) proteins. This increased production
in glomerular mesangial cells has been implicated in the
development of diabetic nephropathy (DN) [16]. In vitro
studies have shown that mesangial cells are the major source
of free radicals after exposure to high glucose concentrationsEvidence-Based Complementary and Alternative Medicine 7
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Figure 6:EﬀectofDangGuionfreeradicalsinglucose-exposedRMCs.(a)DirectfreeradicalscavengingactivityofDangGuiwasdetermined
by the DPPH radical scavenging assay. Values represent the data of three independent experiments (SE < 0.05). Ascorbic acid was used as a
reference compound. (b) DHE stains were used to visualize the intracellular ROS in RMCs. (c) Lucigenin assays were used to quantitate the
generation of superoxide in RMCs. RMCs were cultured in normal glucose (5mmol/L; control) or high glucose (30mmol/L; HG) medium
in the presence of DangGui (200μg/mL) or tiron (10μmol/L) for 24-h incubation. ∗P < 0.05 compared to control, #P < 0.05 compared to
HG.
[3, 25]. Thus, the cultured rat mesangial cells incubated in
the high glucose medium can be used as an in vitro model
in order to investigate diabetic nephropathy in this study. In
cultured cell, endogenous BMP-7 in RMCs was reduced after
24-h high glucose exposure. When endogenous BMP-7 was
reduced by siRNA, as described previously, RMCs lost their
resistance to HG-generated ROS. However, this eﬀect can be
reversed with rhBMP-7 treatment [14]. It was suggested that
BMP-7 has an antioxidative activity. As shown in Figure 4,
the decrease of BMP-7 by high glucose incubation was
reversed by DangGui. However, RMCs transfected with
BMP-7 RNAi were all expired in the high glucose medium
although scramble RNAi-transfected RMCs remained alive
under HG in the preliminary experiment. Thus, BMP-7
seemsessentialinthegrowthofRMCsunderHG.Otherwise,
we knock down BMP-7 expression in RMCs using BMP-7
RNAi successfully in the normal medium (Figure 5). After
12-htransfectionwithscrambleorBMP-7RNAi,wereplaced
thetransfectionconditionalmediumwiththeregularculture
medium containing DangGui to culture for further 24h. We
observed that DangGui increased BMP-7 protein in RMCs
transfected with either scramble RNAi or siBMP-7. One of
the possible reasons for the increase of BMP-7 expression
by DangGui in siBMP-7-transfected RMCs may be related
to the longer lasting time of DangGui (24h) as compared to
siBMP-7 (12h). Nevertheless, the direct activation of BMP-7
expression by DangGui could be considered.
Moreover,DangGuiimprovedtherenalfunctionsandin-
creased BMP-7 expression as the dose failed to modify blood
glucose level in STZ-diabetic rats. It has been documented
that glucose stimulates excessive production of ROS leading
to DN [25]. High glucose-induced ROS is one of the main8 Evidence-Based Complementary and Alternative Medicine
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Figure 7: Hypothesis for the merit of DangGui in decrease of ROS
through a direct eﬀect and/or an increase of BMP-7 expression in
diabetic nephropathy.
reasonsforthedecreaseofBMP-7expressioninthekidneyof
STZ-diabetic rats and/or high glucose-exposed RMCs [25].
DangGui was reported as a native free radical scavenger
[26]. There is no report showing the anti-oxidative stress
of DangGui in diabetic nephropathy. However, some studies
indicated that DangGui has neuroprotective activity through
scavenging free radicals, such as Z-ligustilide from DangGui
protected against H2O2-induced cytotoxicity in PC12 cells
and forebrain I/R by enhancing antioxidant defense [27,
28]. Also, coniferyl ferulate is the main antioxidant from
the essential oil of DangGui [29] and ferulic acid could
reduce neuronal damage from exposure-free radicals [30,
31]. Moreover, the polysaccharides of DangGui may pro-
tect macrophages against tert-butylhydroperoxide-induced
oxidative injury [32, 33]. These reports indicated that Dang-
Gui could protect tissues from oxidative stress. We found
that the action of DangGui in STZ-diabetic rats seems to be
related to the decrease of ROS. The DPPH assay revealed that
DangGui has an ability to scavenge the free radical directly.
DHE stain and lucigenin assay also showed that DangGui
can decrease high glucose-induced ROS in a way as tiron,
the famous ROS scavenger. Taken together, we suggested
that DangGui could decrease ROS in the kidney of diabetic
rats or in mesangial cells generated by HG. In Figure 7,w e
summarized this view that DangGui could increase renal
BMP-7 to prevent the kidney from damage of oxidative stress
produced in diabetic disorders.
In conclusion, DangGui could prevent renal functions
through an increase of endogenous BMP-7 expression and a
direct reduction of ROS. DangGui could be applied for han-
dling of diabetic nephropathy base on its safety after long
used history in TCM.
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